New Presentations Sample Clauses
The "New Presentations" clause establishes the terms under which new or additional presentations, such as documents or materials, may be submitted or required during the course of an agreement or process. Typically, this clause outlines the conditions, timing, and format for submitting these new presentations, and may specify who is authorized to request or provide them. Its core practical function is to ensure that all parties have a clear understanding of how and when new information can be introduced, thereby promoting transparency and reducing the risk of disputes over documentation or procedural requirements.
New Presentations. The Conversion Charge for any New ----------------- Presentations shall be calculated as follows: [*] where (A) is the average per unit (e.g., tablet) Conversion Charge for those presentations of such Secondary/Steriles Product having the same dosage size as the New Presentation; (B) is the unit size of the New Presentation; [*] where (W) is the average per dosage unit (e.g., mg) Conversion Charge for those presentations of such Secondary/Steriles Product having the same package size as the New Presentation; (X) is the dosage size (in units) of the New Presentation; [*] = CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. [*] The Conversion Charge for each New Presentation shall be recalculated following the [*] the New Presentation is supplied under this Agreement (or until that New Presentation is no longer supplied, whichever first occurs), [*] by Supplier with respect to that New Presentation and the actual unit volumes of that New Presentation with Delivery Dates during the period. Incremental costs used in the recalculation shall include only the types of costs included in the initial calculation, and only increases or decreases therein shall be reflected in the recalculation. If the recalculated Conversion Charge exceeds the Conversion Charge calculated prior to the commencement of supply of any such New Presentation, GWI shall promptly pay to Supplier an amount equal to the excess times the number of units of that New Presentation with Delivery Dates in such period. If the recalculated Conversion Charge is less than the Conversion Charge calculated prior to the commencement of supply of any such New Presentation, Supplier shall credit to GWI an amount equal to the difference times the number of units of such New Presentation with Delivery Dates in such period on Supplier's next invoices for Products until fully recovered. The amount of any credits not applied against invoices to GWI as of the Termination Date shall be paid by Supplier to GWI within [*] the Termination Date.
New Presentations. From time to time, GSK may request Draxis to manufacture any of the Products in any package size or dosage size or for shipment into a country not set forth on the applicable Schedule 2.1 (each, a “New Presentation”). Subject to compliance with the provisions of Section 4.3 and Section 3.11(c) of this Agreement, Draxis shall manufacture New Presentations and the Parties shall negotiate in good faith to establish a timeline for commencing manufacture of any New Presentations at the Facility and a price for the New Presentation.